The discoveries of downstream regulatory pathways, directly or indirectly mediated by NANOG, indicate that NANOG regulates several aspects of cancer development, such as self-renewal, tumor cell proliferation, motility, EMT, escape from immune system, and drug resistance, which are all defined features for CSCs42. This evidence concerns the gene NANOG and cancer.